Irinotecan (CPT-11) in patients with advanced colorectal cancer previously treated with 5-fluorouracil-based chemotherapy
- 1 December 1999
- journal article
- clinical trial
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 32 (3) , 209-219
- https://doi.org/10.1016/s1040-8428(99)00045-1
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Should patients with advanced colorectal cancer be treated with chemotherapy?: ProEuropean Journal Of Cancer, 1997
- Colorectal cancer—Is there an alternative to 5-FU?European Journal Of Cancer, 1997
- Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final ReportAnnals of Internal Medicine, 1995
- Cancer statistics, 1994CA: A Cancer Journal for Clinicians, 1994
- Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.BMJ, 1993
- Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.Journal of Clinical Oncology, 1992
- Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial.Journal of Clinical Oncology, 1992
- Systemic therapy in metastatic colorectal cancerArchives of internal medicine (1960), 1990
- Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.Journal of Clinical Oncology, 1989
- Efficacy of adjuvant fluorouracil and folinic acid in colon cancer: International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigatorsPublished by Elsevier